BSE filing, NSE: GODAVARI. Summary written from the filing by ALFA Finder's alert engine.
Godavari Drugs Ltd: key numbers
- Share price
- ₹125.60
- Market cap
- ₹127.2 Cr
- Revenue (annual)
- ₹105.8 Cr
- Net profit (annual)
- ₹4.09 Cr
- P/E (TTM)
- 30.6×Sector 45.9×
- Promoter holding
- 40.23%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Godavari Drugs Ltd
All →Godavari Drugs Other Announcement
Godavari Drugs Limited changed its Corporate Identification Number (CIN) following an alteration to its Memorandum of Association's Object Clause. The Ministry of Corporate Affairs registered the change on October 16, 2026.
Godavari Drugs Debt & Borrowing: ₹34 Cr
Godavari Drugs Limited's board approved availing working capital limits of Rs. 34 Crore from ICICI Bank. The facility is within existing shareholder-approved borrowing limits.
- Value
- ₹34.00 Cr
Godavari Drugs Annual General Meeting
Godavari Drugs held its 38th Annual General Meeting on September 25, 2026, via video conferencing. Shareholders approved financial statements, director re-appointment, and object clause alteration.
Godavari Drugs Annual General Meeting
Godavari Drugs Limited will close its register of members and share transfer books from September 19 to September 25, 2026, for its 38th Annual General Meeting.
Godavari Drugs Board Meeting Outcome
Godavari Drugs approved altering its Memorandum of Association to add a nutraceuticals business object. A revised notice for the 38th AGM was also approved.
Godavari Drugs Capital Structure Change
Godavari Drugs Limited allotted 7,86,690 equity shares to the promoter category following warrant conversion. The company received Rs. 5.25 Crore, representing the final 75% payment.
- Value
- ₹5.25 Cr
Other price movement clarification announcements
All →Gulf Oil Lubricants India Price Movement Clarification
Gulf Oil Lubricants clarified a news item about Gulf Oil International's global expansion plans, stating no negotiations were entered into. The price movement is described as market-driven with no undisclosed event.
Anna Infrastructures Price Movement Clarification
Anna Infrastructures responded to a BSE query on significant price movement, stating no undisclosed price-sensitive information is withheld. It attributes the share price movement to market conditions.
Tera Software Price Movement Clarification
Tera Software responded to BSE and NSE surveillance queries on recent share price movement. The company states there is no unannounced material information and the move is market-driven.
Olatech Solutions Price Movement Clarification
Olatech Solutions said its share price movement was purely market driven, responding to a BSE query. It stated it remains compliant with Regulation 30 disclosures.
Black Opal Consultants Price Movement Clarification
Black Opal Consultants clarified to BSE on recent share price movement. It says no pending price-sensitive information exists and the move appears market-driven.
SJP Ultrasonics Price Movement Clarification
SJP Ultrasonics clarified to BSE that it is unaware of any undisclosed price-sensitive information behind a recent significant share price movement. It cannot comment on the causes, which it attributes to market factors.